MLTX compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

MLTXMoonLake Immunotherapeutics

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

MLTXMoonLake Immunotherapeutics

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

MLTX: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only MLTX 1

—Merck Healthcare KGaA, Darmstadt, Germanyunlistedsupplier

Shared 0

No shared counterparties.

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

25 more · LLY chain ›

Price

rebased to 0%

MLTX, solidLLY, dashed

MLTXMoonLake Immunotherapeutics

11.55· pre 11.55· delayed

Mkt cap$983.8MRevenue—Revenue—

LLYELI Lilly & Co

1,417.89· pre 1,430.00· delayed

Pre-marketNov 5 '26delayed

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

Pre-marketNov 5 '26delayed

MLTXMoonLake Immunotherapeutics

LLYELI Lilly & Co

11.55pre 11.55delayed

Price

1,417.89pre 1,430.00delayed

$983.8M

Mkt cap

$1.3T

—

Revenue

$24.4BQ3 FY26

—

Revenue

$65.2BFY25

MLTX11.55vsLLY1,417.89Pre-marketNov 5 '26delayed